Robbins Wendye

Average Profitability
7.41%
Insider Buys Quantity
18
Insider Buys Sum
$757,916.89
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Robbins Wendye

The largest purchase of all time was on 2020-06-29 and amounted to 4300 shares of RAPT Therapeutics, Inc. for $112,266.

Biography of Robbins Wendye

No biography is available at this moment.

2023-03-14PurchaseRAPT Therapeutics, Inc.
RAPT
director
5,000
0.0152%
$19.52$97,612-2.84%
2022-05-10PurchaseRAPT Therapeutics, Inc.
RAPT
400
0.0012%
$10.62$4,248+85.56%
2021-10-18PurchaseRAPT Therapeutics, Inc.
RAPT
500
0.0016%
$30.70$15,350-28.47%
2021-10-13PurchaseRAPT Therapeutics, Inc.
RAPT
400
0.0013%
$29.69$11,876-25.47%
2021-08-23PurchaseRAPT Therapeutics, Inc.
RAPT
director
3,475
0.0118%
$31.24$108,552-26.84%
2021-08-20PurchaseRAPT Therapeutics, Inc.
RAPT
director
1,200
0.004%
$29.53$35,433-23.91%
2021-07-07PurchaseRAPT Therapeutics, Inc.
RAPT
director
2,000
0.0064%
$30.18$60,360-6.36%
2021-06-16PurchaseRAPT Therapeutics, Inc.
RAPT
director
1,410
0.0054%
$31.54$44,471-3.5%
2021-04-13PurchaseRAPT Therapeutics, Inc.
RAPT
director
1,400
0.0055%
$19.46$27,240+60.19%
2021-04-09PurchaseRAPT Therapeutics, Inc.
RAPT
director
2,800
0.0109%
$21.04$58,924+46.91%
2020-11-19PurchaseRAPT Therapeutics, Inc.
RAPT
director
2,000
0.008%
$16.09$32,175+43.2%
2020-09-28PurchaseRAPT Therapeutics, Inc.
RAPT
director
1,000
0.0041%
$28.70$28,700-19.51%
2020-09-24PurchaseRAPT Therapeutics, Inc.
RAPT
director
200
0.0008%
$28.00$5,600-19.05%
2020-09-23PurchaseRAPT Therapeutics, Inc.
RAPT
director
1,000
0.0041%
$28.96$28,959-20.19%
2020-07-24PurchaseRAPT Therapeutics, Inc.
RAPT
director
1,800
0.0074%
$22.47$40,450+0.36%
2020-07-01PurchaseRAPT Therapeutics, Inc.
RAPT
director
1,000
0.0039%
$26.50$26,500-18.84%
2020-06-29PurchaseRAPT Therapeutics, Inc.
RAPT
director
4,300
0.0173%
$26.11$112,266-15.36%
2019-11-04PurchaseRAPT Therapeutics, Inc.
RAPT
director
1,600
0.0102%
$12.00$19,200+107.48%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.